S. B. Levy and B. Marshall, Antibacterial resistance worldwide: causes, challenges and responses, Nat Med, vol.10, p.15577930, 2004.

J. M. Blair, M. A. Webber, A. J. Baylay, D. O. Ogbolu, and L. J. Piddock, Molecular mechanisms of antibiotic resistance, Nat Rev Microbiol, vol.13, issue.1, pp.42-51, 2015.

H. W. Boucher, G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert et al., Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America, Clin Infect Dis, vol.48, issue.1, p.19035777, 2009.

S. N. Khan and A. U. Khan, Breaking the Spell: Combating Multidrug Resistant, Superbugs'. Front Microbiol, vol.7, p.26925046, 2016.

M. E. De-kraker, A. J. Stewardson, and S. Harbarth, Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050, PLoS Med, vol.13, issue.11, p.27898664, 2016.

J. L. Fox, Antimicrobial peptides stage a comeback, Nat Biotechnol, vol.31, issue.5, p.23657384, 2013.

B. Mishra, S. Reiling, D. Zarena, and G. Wang, Host defense antimicrobial peptides as antibiotics: design and application strategies, Curr Opin Chem Biol, vol.38, p.28399505, 2017.

O. Solecki, A. Mosbah, B. Floc'h, M. Felden, and B. , Converting a Staphylococcus aureus toxin into effective cyclic pseudopeptide antibiotics, Chem Biol, vol.22, issue.3, p.25728268, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01125610

N. Sayed, A. Jousselin, and B. Felden, A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide, Nat Struct Mol Biol, vol.19, issue.1, p.22198463, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00696345

M. Laurencin, B. Legrand, E. Duval, J. Henry, M. Baudy-floc'h et al., From a marine neuropeptide to antimicrobial pseudopeptides containing aza-beta(3)-amino acids: structure and activity, J Med Chem, vol.55, issue.5, p.22320306, 2012.

M. Laurencin, M. Simon, Y. Fleury, M. Baudy-floc'h, A. Bondon et al., Selectivity Modulation and Structure of alpha/aza-beta(3) Cyclic Antimicrobial Peptides, Chemistry, vol.24, issue.23, p.29411917, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01807077

S. T. Micek, Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections, Clin Infect Dis, vol.45, p.17712745, 2007.

Y. Y. Liu, Y. Wang, T. R. Walsh, L. X. Yi, R. Zhang et al., Emergence of plasmid-mediated colistin resistance mechanism MCR?1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect Dis, vol.16, issue.2, p.26603172, 2016.

L. Truong, S. L. Harper, and R. L. Tanguay, Evaluation of embryotoxicity using the zebrafish model, Methods Mol Biol, vol.691, p.20972759, 2011.

T. L. Holland, C. Arnold, and F. Vg, Clinical management of Staphylococcus aureus bacteremia: a review, Jama, vol.312, issue.13, p.25268440, 2014.

E. Tacconelli and W. V. Kern, New antibiotics for skin and skin-structure infections, Lancet Infect Dis, vol.14, issue.8, p.24909500, 2014.

K. Jambunathan and A. K. Galande, Design of a serum stability tag for bioactive peptides, Protein Pept Lett, vol.21, issue.1, p.24354769, 2014.

L. Pabic, H. Germain-amiot, N. Bordeau, V. Felden, and B. , A bacterial regulatory RNA attenuates virulence, spread and human host cell phagocytosis, Nucleic Acids Res, vol.43, issue.19, pp.9232-9280, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01194696

G. Sakoulas, P. A. Moise-broder, J. Schentag, A. Forrest, R. C. Moellering et al., Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia, J Clin Microbiol, vol.42, issue.6, p.15184410, 2004.

R. W. Scott and G. N. Tew, Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications, Curr Top Med Chem, vol.17, issue.5, p.27411325, 2017.

L. F. Mccaig, L. C. Mcdonald, S. Mandal, and D. B. Jernigan, Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care, Emerg Infect Dis, vol.12, issue.11, p.17283622, 2006.

D. Pletzer, S. C. Mansour, K. Wuerth, N. Rahanjam, and R. E. Hancock, New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe Interactions, MBio, vol.8, issue.1, p.28246361, 2017.

R. A. Proctor, A. Kriegeskorte, B. C. Kahl, K. Becker, B. Loffler et al., Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections, Front Cell Infect Microbiol, vol.4, p.25120957, 2014.

M. Bassetti, A. Vena, A. Croxatto, E. Righi, and B. Guery, How to manage Pseudomonas aeruginosa infections, Drugs Context, vol.7, p.29872449, 2018.

B. E. Haug, M. L. Skar, and J. S. Svendsen, Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives, J. Pept. Sci, vol.7, p.11548058, 2001.

U. Theuretzbacher, S. Gottwalt, P. Beyer, M. Butler, L. Czaplewski et al., Analysis of the clinical antibacterial and antituberculosis pipeline, Lancet Infect Dis, vol.19, issue.2, p.30337260, 2018.

B. Mensa, G. L. Howell, R. Scott, and W. F. Degrado, Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16, Antimicrob Agents Chemother, vol.9, p.24936592, 2014.

J. G. Hurdle, A. J. O'neill, I. Chopra, and R. E. Lee, Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections, Nat Rev Microbiol, vol.9, issue.1, p.21164535, 2011.

P. K. Dandekar, P. R. Tessier, P. Williams, C. H. Nightingale, and D. P. Nicolau, Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model, J Antimicrob Chemother, vol.52, issue.3, p.12917254, 2003.

M. Laurencin, M. Amor, Y. Fleury, and . Baudy-floc'h-m, De novo cyclic pseudopeptides containing aza-beta3-amino acids exhibiting antimicrobial activities, J Med Chem, vol.55, issue.24, p.23148564, 2012.

W. Kim, A. L. Conery, R. Rajamuthiah, B. B. Fuchs, F. M. Ausubel et al., Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy, PLoS ONE, vol.10, issue.6, p.26039584, 2015.

V. Dartois, J. Sanchez-quesada, E. Cabezas, C. E. Dubbelde, C. Dunn et al., Systemic antibacterial activity of novel synthetic cyclic peptides, Antimicrob Agents Chemother, vol.49, issue.8, p.16048940, 2005.

L. Mouret, D. Costa, G. Bondon, and A. , Sterols associated with small unilamellar vesicles (SUVs): intrinsic mobility role for 1H NMR detection, Magn Reson Chem, vol.52, issue.7, p.24691941, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01060067

H. Mo, J. S. Harwood, D. Yang, and C. B. Post, A simple method for NMR t1 noise suppression, J Magn Reson, vol.276, p.28103498, 2017.

B. A. Johnson, Using NMRView to visualize and analyze the NMR spectra of macromolecules, Methods Mol Biol, vol.278, p.15318002, 2004.

, Wü thrich K NMR of proteins and nucleic acids, 1986.

D. A. Case, T. E. Cheathami, and T. Darden, The Amber Biomolecular Simulation Programs Wiley InterScience, 2005.

R. Koradi, M. Billeter, and K. Wuthrich, MOLMOL: a program for display and analysis of macromolecular structures, J Mol Graph, vol.14, issue.1, p.8744573, 1996.

E. Krieger, G. Koraimann, and G. Vriend, Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field, Proteins, vol.47, issue.3, p.11948792, 2002.

E. Jurrus, D. Engel, K. Star, K. Monson, J. Brandi et al., Improvements to the APBS biomolecular solvation software suite, Protein Sci, vol.27, issue.1, p.28836357, 2018.

N. A. Baker, D. Sept, S. Joseph, M. J. Holst, and J. A. Mccammon, Electrostatics of nanosystems: application to microtubules and the ribosome, Proc Natl Acad Sci USA, vol.98, issue.18, p.11517324, 2001.

W. Humphrey, A. Dalke, and K. Schulten, VMD: visual molecular dynamics, J Mol Graph, vol.14, issue.1, pp.33-41, 1996.